Compounds > amikacin
Page last updated: 2024-08-23

amikacin and clioquinol

amikacin has been researched along with clioquinol in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (20.00)29.6817
2010's4 (80.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A1
Choi, SS; Contrera, JF; Hastings, KL; Kruhlak, NL; Sancilio, LF; Weaver, JL; Willard, JM1
Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ1
Chiem, K; Hue, F; Magallon, J; Tolmasky, ME1
Chiem, K; Jimenez, V; Magallon, J; Ramirez, MS; Tolmasky, ME; Tran, T1

Other Studies

5 other study(ies) available for amikacin and clioquinol

ArticleYear
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
    Chemical research in toxicology, 2010, Volume: 23, Issue:1

    Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship

2010
Development of a phospholipidosis database and predictive quantitative structure-activity relationship (QSAR) models.
    Toxicology mechanisms and methods, 2008, Volume: 18, Issue:2-3

    Topics:

2008
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
    Toxicological sciences : an official journal of the Society of Toxicology, 2013, Volume: 136, Issue:1

    Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests

2013
Inhibition of aminoglycoside 6'-N-acetyltransferase type Ib-mediated amikacin resistance by zinc complexed with clioquinol, an ionophore active against tumors and neurodegenerative diseases.
    International journal of antimicrobial agents, 2018, Volume: 51, Issue:2

    Topics: Acetyltransferases; Acinetobacter baumannii; Amikacin; Anti-Bacterial Agents; Antineoplastic Agents; Clioquinol; Drug Resistance, Bacterial; Ionophores; Microbial Sensitivity Tests; Neurodegenerative Diseases; Zinc

2018
Restoration of susceptibility to amikacin by 8-hydroxyquinoline analogs complexed to zinc.
    PloS one, 2019, Volume: 14, Issue:5

    Topics: Acetylation; Acinetobacter baumannii; Acinetobacter Infections; Amikacin; Aminoglycosides; Anti-Bacterial Agents; Clioquinol; Drug Hypersensitivity; Drug Resistance, Microbial; Enzyme Inhibitors; HEK293 Cells; Humans; Zinc

2019